SANOFI DIABETES

Contact PR

To use this feature, join Babbler easily !

Download this content

Press release

Sanofi's Toujeo met main objective in head-to-head study versus insulin degludec
timer minutes reading time

Copy link

Sanofi's Toujeo® met the primary study objective in the first large head-to-head clinical trial1, called BRIGHT study, comparing Toujeo with insulin degludec. Sanofi plans to provide full results in 2018. 

  • Health & Medicine
  • Medicine
  • Men's Health
  • Women's Health